What's new

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 11, Status: Authorised

May 8, 2025 - 08:46
 0
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, ...

Next Article

Easter holiday and warm weather boost footfall

Related Posts

Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

Herbal medicinal product: Uvae ursi folium, Arctostaphylos uva-ursi (L.) Spreng., C: ongoing call for scientific data

Herbal medicinal product: Uvae ursi folium, Arctostaphy...

Apr 30, 2025  0

Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Date of authorisation: 03/10/2011, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 30, 2025  0